Skip to main content
Clinical Trials/ISRCTN63226989
ISRCTN63226989CompletedNot Applicable

The dopaminergic system in patients with functional dyspepsia analyzed by an alpha-methyl-para-tyrosine (AMPT) challenge test and single photon emission computed tomography (SPECT) imaging before and after treatment with amitriptyline

Academic Medical Center (AMC), Department of Gastroenterology (The Netherlands)0 sites60 target enrollmentStarted: June 7, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Age 18-65 years
  • 2. Functional dyspepsia (Nepean dyspepsia index [NDI] >25)
  • 3. Take part in the amitriptyline study (ISRCTN76116512)
  • 4. No effect on proton pump inhibitor (PPI), or a constant three-month dosage of PPI
  • 5. No depression (Zung self-rating depression scale <50)
  • 6. No medications which influence the intestine

Exclusion Criteria

  • 1. Gastroduodenal surgery
  • 2. Reflux-like dyspepsia (Rome II criteria)
  • 3. Use of antidepressants
  • 4. Organic abnormalities
  • 5. Pregnancy
  • 6. Severe cardiac, renal, pulmonary, hepatic or systemic diseases, hyperthyroidism, glaucoma and epilepsy
  • 7. Metal implants

Investigators

Sponsor
Academic Medical Center (AMC), Department of Gastroenterology (The Netherlands)

Similar Trials